Ravulizumab
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for Ravulizumab, covering 2019-02-12 to 2026-06-30. Get the full timeline:
Most recent: Clinical Trial Update: ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE [Phase 3]